Quick Answer
bioAffinity Technologies, Inc. reported Total Revenue of $6.16 million for fiscal year 2025.
bioAffinity Technologies, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $6.16M | -34.2% |
| 2024 | $9.36M | +269.7% |
| 2023 | $2.53M | +52627.4% |
| 2022 | $4.8K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.45M | -38.5% | +13.9% |
| June 30, 2025 | $1.27M | -47.1% | -31.5% |
| March 31, 2025 | $1.85M | -23.0% | -21.1% |
| September 30, 2024 | $2.35M | +687.4% | -2.0% |
| June 30, 2024 | $2.40M | +12047.4% | -0.4% |
| March 31, 2024 | $2.41M | +261180.2% | +706.2% |
| September 30, 2023 | $298.5K | +25855.1% | +1412.2% |
| June 30, 2023 | $19.7K | +1411.3% | +2043.1% |
- bioAffinity Technologies, Inc. showed a decrease of -34.2% in Total Revenue compared to the prior fiscal year.
- Over the 2022–2025 period, bioAffinity Technologies, Inc.’s total revenue has grown by 128194.0% (from $4.8 thousand to $6.16 million).
- The most recent figure is from bioAffinity Technologies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: